Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 13.34
-5.52 %
$ 1.61 B
Market Cap
-8.78
P/E
BALANCE SHEET
965 M
ASSETS
224 M
LIABILITIES
741 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
10x Genomics, Inc.
| Current Assets | 596 M |
| Cash & Short-Term Investments | 389 M |
| Receivables | 115 M |
| Other Current Assets | 92.5 M |
| Non-Current Assets | 369 M |
| Long-Term Investments | 0 |
| PP&E | 345 M |
| Other Non-Current Assets | 24.2 M |
| Current Liabilities | 127 M |
| Accounts Payable | 15.7 M |
| Short-Term Debt | 23 M |
| Other Current Liabilities | 88.4 M |
| Non-Current Liabilities | 96.9 M |
| Long-Term Debt | 168 M |
| Other Non-Current Liabilities | -70.8 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 359.3 | 219.7 | 587.4 | 663.6 | 424.2 | 65.1 | 47.9 |
| Short Term Investments | 29.4 | 210.2 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 114.8 | 104.2 | 85.3 | 51.2 | 33.4 | 28.1 | 13.3 |
| Inventory | 73.7 | 81.6 | 60.0 | 30.0 | 15.3 | 8.6 | 4.8 |
| Other Current Assets | 18.8 | 19.2 | 28.8 | 42.6 | 16.1 | 4.5 | 4.1 |
| Total Current Assets | 596.0 | 635.0 | 747.6 | 774.4 | 480.8 | 106.2 | 68.1 |
| PP&E | 344.9 | 359.2 | 230.4 | 119.8 | 48.8 | 11.1 | 6.9 |
| Intangible Assets | 16.6 | 22.9 | 25.4 | 22.4 | 22.4 | 0 | 0 |
| Goodwill | 4.5 | 4.5 | 4.5 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 5.0 | 7.6 | 8.5 | 52.3 | 5.0 | 0 |
| Other Long Term Assets | 3.1 | 7.4 | 10.9 | 12.8 | 76.3 | 1.9 | 0.6 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 965.1 | 1 029.0 | 1 018.8 | 929.3 | 605.9 | 124.3 | 75.6 |
| LIABILITIES | |||||||
| Accounts Payable | 15.7 | 21.6 | 17.4 | 4.7 | 13.0 | 8.8 | 5.4 |
| Short Term Debt | 23.0 | 18.1 | 10.3 | 11.9 | 9.9 | 4.2 | 4.2 |
| Other Current Liabilities | 70.2 | 79.3 | 72.8 | 88.4 | 35.8 | 16.2 | 11.2 |
| Total Current Liabilities | 127.2 | 131.0 | 110.4 | 118.1 | 63.0 | 32.4 | 22.1 |
| Long Term Debt | 167.7 | 172.3 | 153.7 | 114.1 | 19.8 | 25.5 | 6.3 |
| Deferred Tax Income | (83.8) | (3.2) | 0 | 0 | 101.0 | 284.6 | 158.4 |
| Other Liabilities | (79.6) | (80.0) | (62.8) | (41.9) | 102.1 | 0.8 | 0.5 |
| Total Liabilities | 224.1 | 223.2 | 201.3 | 190.3 | 185.8 | 344.3 | 188.1 |
| EQUITY | |||||||
| Common Stock | 2 K | 2 K | 2 K | 2 K | 2 K | 1 K | 1 K |
| Retained Earnings | (1 284.4) | (1 029.3) | (863.3) | (805.1) | (262.4) | (231.1) | (118.6) |
| Other Accumulative Comprehensive Income/Loss | (0.4) | (4.3) | 22 K | 50 K | 46 K | 37 K | 15 K |
| Total Equity | 741.0 | 805.7 | 817.6 | 739.1 | 420.1 | (220.0) | (112.5) |
| Total Liabilities and Equity | 965.1 | 1 029.0 | 1 018.8 | 929.3 | 605.9 | 124.3 | 75.6 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 117.2 | 113.9 | 110.3 | 101.2 | 39.1 | 13.4 | 11.6 |